Published in J Immunol Methods on July 11, 1986
Limiting concentrations of human basophil-bound IgE antibody required for histamine release. Immunology (1988) 0.87
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med (1983) 1.69
Simultaneous activation of NADPH oxidase-related proton and electron currents in human neutrophils. Proc Natl Acad Sci U S A (2000) 1.58
Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J Leukoc Biol (1999) 1.49
Interactions between NADPH oxidase-related proton and electron currents in human eosinophils. J Physiol (2001) 1.46
Purification of cardiac myosin. Application to hypertrophied myocardium. Biochim Biophys Acta (1975) 1.37
Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol (1984) 1.35
Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol (1992) 1.24
Activation of NADPH oxidase-related proton and electron currents in human eosinophils by arachidonic acid. J Physiol (2001) 1.24
The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes. J Immunol (1980) 1.19
Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood (1997) 1.05
Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. J Immunol (1990) 1.02
Quantitative endotoxin determination in blood with a chromogenic substrate. Clin Chim Acta (1981) 1.01
A novel and highly divergent homolog of human eosinophil granule major basic protein. J Biol Chem (1999) 0.96
High school students' long-term retention of sex education information. J Sch Health (1985) 0.94
Methylxanthine bronchodilators potentiate multiple human neutrophil functions. J Immunol (1987) 0.94
Sarcoidosis associated with autoimmune thrombocytopenia and selective IgA deficiency. Scand J Haematol (1982) 0.93
Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment? Br J Haematol (1995) 0.92
Analysis of signaling events associated with activation of neutrophil superoxide anion production by eosinophil granule major basic protein. Blood (1995) 0.88
Endotoxin testing in blood. Prog Clin Biol Res (1987) 0.88
The role of basophils in inflammatory reactions. J Invest Dermatol (1978) 0.87
The anti-inflammatory actions of tilorone hydrochloride. Proc Soc Exp Biol Med (1975) 0.87
Surface expression of lactoferrin by resting neutrophils. Biochem Biophys Res Commun (2000) 0.86
Immune response to GOR, a marker for non-A, non-B hepatitis and its correlation with hepatitis C virus infection. J Clin Immunol (1992) 0.85
Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures. Am J Clin Pathol (1984) 0.84
Functional integrity of the SH1 site in myosin from hypertrophied myocardium. Biochim Biophys Acta (1977) 0.84
Cyclic nucleotides in immune responses and allergy. Adv Cyclic Nucleotide Res (1980) 0.84
Optimalization of a chromogenic assay for endotoxin in blood. Prog Clin Biol Res (1985) 0.82
Molecular cloning and expression of an inwardly rectifying K(+) channel from bovine corneal endothelial cells. Invest Ophthalmol Vis Sci (2000) 0.82
Massive vincristine overdose: failure of leucovorin to reduce toxicity. Cancer Treat Rep (1982) 0.81
Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. Am J Respir Cell Mol Biol (1999) 0.81
IgE-mediated basophil phenomena: quantitation, control, inflammatory interactions. Immunol Rev (1978) 0.80
IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein. J Immunol (1995) 0.80
IMVP-16 followed by high dose chemotherapy and autologous bone marrow transplantation as salvage treatment for malignant lymphoma. Hematol Oncol (1992) 0.79
Increases in cytosolic Ca2+ accompany basophil activation by eosinophil granule major basic protein. Immunol Lett (1997) 0.79
Human basophils selectively express the Fc gamma RII (CDw32) subtype of IgG receptor. J Allergy Clin Immunol (1989) 0.79
Eosinophil major basic protein enhances the expression of neutrophil CR3 and p150,95. J Allergy Clin Immunol (1993) 0.78
The effect of tilorone on the local graft-versus-host reaction in rats. Transplantation (1976) 0.78
Galactosamine hepatitis, endotoxemia, and lactulose. Hepatology (1983) 0.78
Growth of aortic explants and arteriosclerosis. Nature (1967) 0.78
Characterization of cyclic-nucleotide phosphodiesterase activities in resting and N-formylmethionylleucylphenylalanine-stimulated human neutrophils. Biochim Biophys Acta (1986) 0.78
Charcot-Leyden crystal protein in the degranulation and recovery of activated basophils. J Leukoc Biol (1992) 0.78
Potentiation of human basophil histamine release by protamine: a new role for a polycation recognition site. Mol Immunol (1986) 0.78
Validity of the endotoxin assay in post surgical patients. Prog Clin Biol Res (1985) 0.78
Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic protein. J Immunol (1995) 0.77
Augmentation of antigen-stimulated histamine release from human basophils by serum-treated zymosan particles. II. Dependence on IgE-mediated release. J Immunol (1979) 0.77
Augmentation of antigen-stimulated histamine release from human basophils by serum-treated zymosan particles. I. Characteristics of enhancement. J Immunol (1979) 0.77
Effects of erythropoietin and aminoguanidine on red blood cell deformability in diabetic azotemic and uremic patients. Am J Kidney Dis (2001) 0.77
Treatment of azotemic, nonoliguric, anemic patients with human recombinant erythropoietin raises whole-blood viscosity proportional to hematocrit. Nephron (1991) 0.77
Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma. Eur J Cancer Clin Oncol (1988) 0.76
Social skills training in the rehabilitation of patients with traumatic closed head injury. Arch Phys Med Rehabil (1988) 0.76
Discordant and anomalous results among cytotoxicity assays: the confounding properties of eosinophil granule major basic protein on cell viability assays. J Immunol Methods (1999) 0.76
Inhibition of human polymorphonuclear leukocyte-derived histaminase activity by H-2 antagonists. Biochem Pharmacol (1978) 0.76
Effect of the calcium ionophore A23187 and aspirin on histamine release in vitro from leukocytes of aspirin-intolerant donors. Int Arch Allergy Appl Immunol (1984) 0.76
High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia. Br Med J (Clin Res Ed) (1988) 0.75
IgE-mediated sensitivity to Trichophyton rubrum in a patient with chronic dermatophytosis and Cushing's syndrome. J Allergy Clin Immunol (1988) 0.75
The thyroid in the spontaneously hypertensive rat: a light and electron microscopic study. Am J Anat (1977) 0.75
Physician house calls: a complement to hospital-based medical care. J Am Geriatr Soc (1977) 0.75
Pneumocystis carinii pneumonia in HIV-negative patients with haematologic disease. Infection (1997) 0.75
[Current approach to the management of patients with hemato-oncologic diseases]. Ned Tijdschr Geneeskd (1987) 0.75
Acute ischaemic cerebrovascular accident after autologous bone marrow transplantation. Eur J Haematol (1996) 0.75
Bone-marrow aspiration. Br Med J (Clin Res Ed) (1981) 0.75
Effect of solvent on the histamine-releasing, enzyme-releasing, and mitogenic properties of the calcium ionophore A23187. Immunopharmacology (1979) 0.75
Donor sensitivity to basophil activation by eosinophil granule major basic protein. Int Arch Allergy Appl Immunol (1985) 0.75
Chromogenic endotoxin determination in blood--clinical relevance. Klin Wochenschr (1982) 0.75
Effectiveness of low dose cyclosporine in acquired aplastic anaemia with severe neutropenia. Neth J Med (1992) 0.75
Chronic lymphocytic leukaemia and associated second malignancy. Neth J Med (1986) 0.75
Inhibition of glucose utilization for acetylcholine synthesis by cerebrospinal fluid. J Neurochem (1976) 0.75
Quantitative chromogenic endotoxin determination in cerebrospinal fluid. Clin Chim Acta (1983) 0.75
Interrelationships of locus of control content dimensions and hopelessness. J Clin Psychol (1985) 0.75